Skip to content

Drug interactions

Nilutamide + Vincristine liposomal

Severity: Moderate

Nilutamide and Vincristine liposomal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vincristine is cleared via CYP3A4, so a CYP3A4 inhibitor could raise its exposure and increase neurotoxicity. Nilutamide is at most a weak inhibitor, so the effect is probably small.

What this interaction means in plain words

Nilutamide and Vincristine liposomal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Nilutamide may inhibit CYP3A4, reducing vincristine metabolism.

What to do

Monitor for peripheral neuropathy, constipation and other signs of vincristine toxicity. Reduce the vincristine dose if neurotoxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilutamide and Vincristine liposomal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Nilutamide with Vincristine liposomal?

MediHelp rates the interaction as moderate. Nilutamide and Vincristine liposomal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Vincristine is cleared via CYP3A4, so a CYP3A4 inhibitor could raise its exposure and increase neurotoxicity. Nilutamide is at most a weak inhibitor, so the effect is probably small.

How serious is the interaction between Nilutamide and Vincristine liposomal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for peripheral neuropathy, constipation and other signs of vincristine toxicity. Reduce the vincristine dose if neurotoxicity develops.

What other medicines interact with Nilutamide?

MediHelp also lists interactions of Nilutamide with, for example, Dihydroergotamine intranasal, Mavacamten, Artemether / lumefantrine. The full list is on the Nilutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in